C07C 251/34
With oxygen atoms of oxyimino groups bound to hydrogen atoms or to
Official title: with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
C07C251/34 (With oxygen atoms of oxyimino groups bound to hydrogen atoms or to) appears on 861 US grants and 541 published applications in this corpus.
Search patents in C07C- Granted patents
- 861
- Published applications
- 541
- Assignees
- 382
- Inventors
- 2,258
- Latest grant
- 4 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 11 | 0 |
| 1977 | 1 | 0 |
| 1978 | 2 | 0 |
| 1979 | 2 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 5 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 8 | 0 |
| 1990 | 7 | 0 |
| 1991 | 21 | 0 |
| 1992 | 19 | 0 |
| 1993 | 24 | 0 |
| 1994 | 23 | 0 |
| 1995 | 27 | 0 |
| 1996 | 50 | 0 |
| 1997 | 59 | 0 |
| 1998 | 37 | 0 |
| 1999 | 44 | 0 |
| 2000 | 43 | 0 |
| 2001 | 47 | 9 |
| 2002 | 38 | 28 |
| 2003 | 25 | 27 |
| 2004 | 20 | 42 |
| 2005 | 15 | 18 |
| 2006 | 16 | 22 |
| 2007 | 18 | 22 |
| 2008 | 19 | 25 |
| 2009 | 15 | 25 |
| 2010 | 16 | 21 |
| 2011 | 18 | 26 |
| 2012 | 15 | 20 |
| 2013 | 15 | 27 |
| 2014 | 17 | 19 |
| 2015 | 30 | 33 |
| 2016 | 23 | 27 |
| 2017 | 18 | 24 |
| 2018 | 17 | 21 |
| 2019 | 17 | 14 |
| 2020 | 21 | 18 |
| 2021 | 8 | 10 |
| 2022 | 10 | 22 |
| 2023 | 12 | 13 |
| 2024 | 7 | 15 |
| 2025 | 11 | 7 |
| 2026 | 5 | 6 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C07C 251/48With the carbon atom of at least one of the oxyimino groups372
- C07C 251/36With the carbon atoms of the oxyimino groups bound to hydrogen atoms328
- C07C 251/44With the carbon atom of at least one of the oxyimino groups158
- C07C 251/42With the carbon atom of at least one of the oxyimino groups68
Recent patents
- Compositions and methods of making expanded hematopoietic stem cells using derivatives of fluorene4 Aug 2026US 12,698,255 B2ImmuneBridge Inc.
- Substrate treating method16 Jun 2026US 12,660,547 B2SCREEN Holdings Co., Ltd.
- Styryl carboxylate derivatives26 May 2026US 12,637,409 B2Renovel Innovations, Inc.
- Inhibitors of YAP/TAZ-TEAD oncoproteins, synthesis and use thereof24 Mar 2026US 12,583,815 B2BridGene Biosciences, Inc.
- 4-membered ring carboxamides used as nematicides6 Jan 2026US RE50,724 E1Syngenta Crop Protection AG
- Aldoxime antibiotics and related methods24 Sep 2026US 2026/0283985 A1
- Novel lipids and compositions for the delivery of therapeutics13 Aug 2026US 2026/0232810 A1Arbutus Biopharma Corporation
- New process for the manufacture of mdm2-p53 antagonists23 Jul 2026US 2026/0209169 A1Boehringer Ingelheim International GmbH
- Urease inhibiting composition and use of same19 Mar 2026US 2026/0078068 A1Fertinagro Biotech, S.L.
- Compounds and compositions for intracellular delivery of therapeutic agents12 Mar 2026US 2026/0069549 A1ModernaTX, Inc.
Most cited
By later US patents
- Retroviral protease inhibiting compounds159US 5,142,056 AAbbott Laboratories · 1992
- Bicyclic naphthalenic derivatives, a process for preparing the same and human or veterinary medicines and cosmetic compositions containing said derivatives142US 4,826,969 ACentre International de Recherches Dermatologiques (C.I.R.D.) · 1989
- Retroviral protease inhibiting compounds109US 5,354,866 AAbbott Laboratories · 1994
- Lipids and compositions for the delivery of therapeutics102US 8,999,351 B2Tekmira Pharmaceuticals Corporation · 2015
- Lipids and compositions for the delivery of therapeutics101US 9,186,325 B2Tekmira Pharmaceuticals Corporation · 2015